The effects of nutrient depleted microenvironments and delta-like 1 homologue (DLK1) on apoptosis in neuroblastoma by Kim, Yuri
Nutrition Research and Practice (Nutr Res Pract) 2010;4(6):455-461
DOI: 10.4162/nrp.2010.4.6.455
The effects of nutrient depleted microenvironments and delta-like 1 homologue (DLK1)
on apoptosis in neuroblastoma
Yuri Kim
§
Department of Nutritional Science and Food Management, Ewha Womans University, 11-1 Daehyun-dong, Seodaemun-gu, Seoul 
120-750, Korea
Abstract
The tumor microenvironment, particularly sufficient nutrition and oxygen supply, is important for tumor cell survival. Nutrition deprivation causes
cancer cell death. Since apoptosis is a major mechanism of neuronal loss, we explored neuronal apoptosis in various microenvironment conditions
employing neuroblastoma (NB) cells. To investigate the effects of tumor malignancy and differentiation on apoptosis, the cells were exposed to
poor microenvironments characterized as serum-free, low-glucose, and hypoxia. Incubation of the cells in serum-free and low-glucose environments 
significantly increased apoptosis in less malignant and more differentiated N-type IMR32 cells, whereas more malignant and less differentiated I-type
BE(2)C cells were not affected by those treatments. In contrast, hypoxia (1% O2) did not affect apoptosis despite cell malignancy. It is suggested
that DLK1 constitutes an important stem cell pathway for regulating self-renewal, clonogenicity, and tumorigenicity. This raises questions about
the role of DLK1 in the cellular resistance of cancer cells under poor microenvironments, which cancer cells normally encounter. In the present
study, DLK1 overexpression resulted in marked protection from apoptosis induced by nutrient deprivation. This in vitro model demonstrated that 
increasing severity of nutrition deprivation and knock-down of DLK1 caused greater apoptotic death, which could be a useful strategy for targeted 
therapies in fighting NB as well as for evaluating how nutrient deprived cells respond to therapeutic manipulation.
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Introduction2)
Sufficient nutrients and oxygen are important to maintain 
tumor growth. Glucose is a major energy source in neural tissues, 
and the brain is dependent on glucose for its metabolic function. 
Since high glucose is required for tumor cells, brain tumors may 
be responsive to dietary and nutritional therapy. Nutrient 
depletion has been shown to cause cancer cell death [1,2]. 
Inadequate nutrient supply affects neuronal cell survival and 
causes damage to neuronal cells leading to apoptosis [3]. Apoptosis, 
programmed cell death, is a self-defense mechanism to remove 
potentially dangerous and damaged cells, or tumor cells. 
Apoptosis has morphologically distinct features such as nucleus 
and cytoplasm condensation as well as DNA fragmentation [4]. 
Apoptosis can be induced by various cytotoxic stimuli such as 
tumor necrosis factor α (TNFα), and nutrient deprivation including 
serum or glucose withdrawal [4-6]. It has been widely reported 
that nutrient deprivation causes tumor cell death through apoptotic 
pathways.
Neuroblastoma (NB) is the most common extracranial solid 
tumor in children [7]. NB originates from multipotent neural crest 
stem cells and is comprised of multiple cell phenotypes. NB 
tumors have high levels of cellular heterogeneity with cells at 
different stages of differentiation including neuroblasts, non- 
neuronal cells, and melanocytes [8]. There are three distinct cell 
types identified in NB cell lines and in primary NB tumors: the 
neuroblastic/neuroendocrine precursors (N-type), Schwannian/ 
melanoblastic precursors, and non-neuronal cells (S-type), and 
cells with intermediate stem cells (I-type) [8-10]. Although the 
three cell types are multipotent and have the potential to 
differentiate further to neural crest cells, in particular, I-type stem 
cells can stably differentiate into either N- or S-type cells [8,11], 
indicating that I-type stem cells are precursors to both N- and 
S-type cells. Most importantly, the frequency of I-type cells is 
strongly increased in advanced NB. I-type cells exhibit the 
highest malignancy potential of all three types, whereas S-type 
cells are the least tumorigenic and N-type cells have an 
intermediate level of tumorigenicity [7]. These observations 
suggest that I-type cells represent the most immature and highly 
malignant NB cells. Although microenvironments in tumor have 
been widely documented, little is known about how different NB 
cell types respond to these conditions.
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DLK1 (Drosophila delta-like 1 homologue) is a type I 
transmembrane protein and secreted protein belonging to the 
epidermal growth factor (EGF)-like homeotic gene family. 
Preadipocyte factor 1 (pref-1), fetal antigen (FA1), pG2, and 
ZOG are other names for DLK1 [12]. DLK1 is expressed in 
animals from birds to mammals extensively in immature cells, 
and is down-regulated during fetal development, which implicates 
that DLK1 plays an important role in fetal development and 
growth. However, DLK1 is only detected in selected adult tissues 
and several tumor cells including NB [13,14], gliomas [15], 
small-cell lung carcinoma [14], and leukemia [16,17]. Previous 
studies have demonstrated that exogenous DLK1 increased NB 
cell clonogenic growth, which is a self-renewal characteristics 
of cancer stem cells [18], and regulated growth of pre-B cells 
and thymocytes [19,20]. Those results suggest that DLK1 
performs an important role in stem/progenitor and cancer cell 
growth. However, the functional role of DLK1 in cellular 
resistant to poor microenvironments is still not well elucidated. 
The aim of this study was to evaluate the potential role of DLK1 
in cancer cell survival and the malignancy of NB cells in nutrient 
deprivation-induced apoptosis.
Materials and Methods
Cell culture 
The following two NB cell lines were used: SK-N-BE(2)C 
[BE(2)C] cells that were maintained in Minimum Essential 
Medium and F12 (1:1), and IMR32 cells that were kept in 
Minimum Essential Medium supplemented with 10% fetal bovine 
serum (v/v). The cells were cultured with 5% CO2 and 95% 
atmospheric air at 37℃. The media were supplemented with 10% 
fetal bovine serum (v/v) (FBS) unless indicated otherwise. For 
all experiments, both BE(2)C and IMR32 cells were cultured to 
60-80% confluence. Fresh medium was replaced every other day.
Induction of nutrient deprivation and hypoxia 
In order to induce serum depletion, the media were replaced 
with serum-free media. For glucose deprivation, after washing 
two times with PBS, the media were replaced with media 
containing 10% (v/v) FBS and 25 μM glucose, unless indicated 
otherwise. The cells were maintained in serum- or glucose- 
deprived media for 48 hr. For hypoxia (1% O2) treatment, the 
cells were transferred to a hypoxia chamber (Invivo2 400, 
Ruskinn Technology) and then maintained for 48 hr.
Gene expression constructs
DLK1-FL (full-length protein) expression and control vector 
constructs were kindly provided by Dr. R. Bhatia (City of Hope 
National Medical Center, Duarte, CA [21]). The DLK1-FL 
construct was cloned into a MIG-R1 retroviral vector containing 
the GFP gene under the control of an internal ribosome entry 
site (IRES). For viral infection to express DLK1-FL, IMR32 cells 
were infected at 50-60% confluence, which was performed as 
described previously [22]. The sequence was confirmed by DNA 
sequencing. The empty retroviral vector was used as a negative 
control. DLK1 expression was verified by Western blotting. 
RNA interference 
Two siRNA oligonucleotides against human DLK1 were 
purchased from Dharmacon (Lafayette, CO). The sequences for 
the two siRNAs were as follows: DLK1 siRNA (05): 5’-GCACC 
UGCGUGGAUGAUGAUU-3’, and DLK1 siRNA (07): 5’-GGA 
CGAUGGCCUCUAUGAAUU-3’. The sequence of the control 
siRNA was UAACAAUGAGAGCACGGCUUU. Transfection 
with the siRNAs was performed using DharmaFECT (Dharmacon, 
Lafayette, CO) according to the manufacturer’s instructions.
Cell death and apoptosis analysis
Apoptosis was analyzed by double staining with propidium 
iodide [PI; 3,8-diamino-5-(3-(diethyl-mehylamino)propyl)-6-phenyl 
phenanthridinium diiodide; Sigma, St. Louis, MO] and Hoechst 
33342 (Hoechst; Sigma, St. Louis, MO) staining. After treatment 
of hypoxia and/or nutrient deprivation for 48 hours, the cells 
were washed with ice-cold PBS and fixed in paraformaldehyde 
solution. PI is widely used to evaluate neuronal membrane 
integrity and cell damage. 20 μl of 0.1 mM PI was added to 
the culture medium for 5 min at room temperature, leading to 
a final concentration of 2 μM PI. For Hoechst staining, the cells 
were stained with 2 μg/ml of Hoechst dye for 5 min at room 
temperature. PI uptake (red fluorescence) and Hoechst uptake 
(blue fluorescence) were observed, and photographed with a 
fluorescence microscope for image detection. Apoptotic cells 
were characterized by nuclear condensation/fragmentation 
revealed by nuclear staining with PI and Hoechst. Apoptosis was 
quantified by averaging cell counts in three to four randomly 
selected fields per dish. To evaluate the apoptotic cells, the ratio 
of both stained cells to total nuclei (%) was calculated. 
Western blotting
The cell cultures were washed with cold PBS and lysates were 
prepared on ice in RIPA lysis buffer containing 50 mM Tris-Cl 
(pH 7.5), 150 mM NaCl, 1% Nonidet p-40, 0.5% sodium 
deoxycholate, 0.1% sodium dodecyl sulfate, and 1-2 mM PMSF. 
After protein concentrations were measured using BCA assay 
reagents (BioRad), 100 μg of whole cell lysate was used for 
10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE), and the separated proteins were transferred to a 
PVDF membrane. The membrane was blocked in 5% fat-free 
milk in Tris-buffered saline (TBS) for 1 hr at room temperature Yuri Kim 457
Fig. 1. Propidium iodide (PI) and Hoechst 33342 (Hoechst) staining demonstrate 
the appearance of nuclei with condensed chromatin in NB cells. BE(2)C cells 
(A) and IMR32 cells (B) were maintained with (left panels) or without (right panels) 
serum in media for 48 hr and then stained with PI (red) and Hoechst (blue) to visualize 
nuclear  morphological  changes  (arrow).  Both  PI-and  Hoechst-positive  cells  were 
counted as apoptotic cells. Images were detected by a fluorescence microscope. 
Magnification = x100.
Fig. 2. More malignant I-type cells showed less apoptosis induced by serum 
deprivation.  M o r e  a d v a n c e d  a n d  l e s s  d i f f e r e n t i a t e d  I - t y p e  B E ( 2 ) C  c e l l s  a n d  l ess 
advanced  and  more  differentiated  IMR32  cells  were  incubated  at  different 
concentrations  of  serum  (10%,  1%,  or  0%).  After  48  hours,  the  cells  were  fixed 
and double stained with PI and Hoechst to evaluate apoptosis. Apoptotic cells with 
compromised  membranes  were  positive  for  PI  staining.  Both  PI-  and  Hoechst- 
positive cells were counted as apoptotic cells. A total of ≥ 300 cells were counted 
in 3-4 random fields. Bars are means ± SE. Different letters for given bars indicate 
the values are significantly different from each other (P < 0.05) (Tukey’s Post Hoc 
t e s t  a f t e r  o n e - w a y  A N O V A ) .
and was then incubated overnight at 4℃ with polyclonal antibody 
against DLK1 (1:3,000, Chemicon International, Temecula, CA) 
and anti β-actin (Sigma, St. Louis, MO). After washing three 
times with TBS, the membrane was further incubated with 
horse-radish peroxidase-conjugated anti-IgG antibody as a 
secondary antibody for 1 hr at room temperature to detect protein 
bands to which the primary antibodies were bound, using 
enhanced chemiluminescence (Pierce, Rockfold, IL).
Statistical analysis
The significant differences between different groups were 
analyzed using a one-way ANOVA analysis with Tukey’s 
post-hoc test as a multiple comparison post test. When only two 
groups were statistically compared, unpaired Student’s t-test was 
performed using Prizm 3.0 (GraphPad Software Inc. San Diego, 
CA, USA). All results are expressed as means ± SE. A significant 
difference between two groups was declared if P <0 . 0 5 .
Results
Advanced malignant cell type shows less apoptosis induced by 
serum deprivation
Apoptosis assessment was performed based on nuclear 
morphology changes. BE(2)C and IMR32 cells were maintained 
in serum-starved media for 48 hr and then underwent double 
staining with PI and Hoechst. Apoptotic cells are positive for 
PI staining and display abnormal nuclear morphologies as 
revealed by Hoechst staining. The cells exhibited nuclear 
blebbing, indicating chromatin condensation characteristic of 
apoptosis (Fig. 1).
There are three phenotypes of the NB cell line, including 
N-type, S-type, and I-type. I type cells exhibit the highest 
tumorigenicity among the three types and are increased in 
advanced NB. To examine the association between cell 
malignancy and apoptosis induced by serum-deprivation, the 
more advanced I-type BE(2)C cells and the less malignant N-type 
IMR32 cells were treated with different concentrations of serum, 
and apoptosis was evaluated by double staining with PI and 
Hoechst. The percentage of apoptotic cells was not significantly 
different at any serum concentration dosage in more advanced 
and less differentiated I-type BE(2)C cells. However, the 
percentage of apoptotic cells was increased as serum 
concentration decreased in less malignant and more differentiated 
IMR32 cells (Fig. 1 and 2). These observations suggest that I-type 
cells, representing the most immature and highly malignant cells, 
were more resistant to apoptosis induced by serum deprivation 
compared to more mature and less malignant N-type cells. It 
is also implicated that NB malignancy may potentially be an 
important factor for apoptosis and resist chemotherapy that 
induces apoptosis. 
The effects of the tumor microenvironment (nutrient deprivation 
and hypoxia) on apoptosis
In order to determine the effect of the microenvironment on 
apoptosis in NB, different malignancy state BE(2)C and IMR32 
cells were incubated at various combinations of nutrient 
deprivation, including serum- and/or glucose-deprivation, as well 
as hypoxia. When BE(2)C cells were exposed to a combination 
of serum-free and low-glucose, apoptosis was increased 
significantly. However, the treatment of serum-free or low 
glucose alone was not sufficient to enhance apoptosis. On the 458 Nutrient depleted microenvironments and apoptosis
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Fig. 3. The effect of tumor microenvironment (nutrient deprivation and hypoxia) on apoptosis. (A) BE(2)C and IMR32 cells were incubated at different combinations of 
nutrient deprivation (S+G, S+LG, SF+G, and SF+LG) for 48 hr. (B) BE(2)C and IMR32 cells were incubated under combination of hypoxia and serum deprivation (N+S, N+SF,
H+S,  and  H+SF)  for  48  hr.  Determination  of  apotosis  was  performed as  described in  Fig. 2.  A total of ≥ 300  cells were  counted  in  3-4 random  fields. Bars are  means
± SE. Different letters for given bars indicate the values are significant different from each other (P < 0.05) (Tukey’s Post Hoc test after one-way ANOVA). S, 10% FBS (v.v); 
SF,  serum-free;  G,  25  mM  of  glucose;  LG,  low-glucose  (25  μM);  N,  normoxia  (21%  O2);  H,  hypoxia  (1%  O2)
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Fig. 4. DLK1 ameliorated nutrient depletion-induced apoptosis. (A) IMR32 cells were infected with full length DLK1 (DLK1-FL).  Western blotting was performed to verify 
the over-expression of DLK1. β-actin was used as a loading control. (B) DLK1 over-expressed IMR32 cells were shifted to various conditions of media and maintained for 
48h. The determination of apotosis was performed as described in Fig. 2. A total of ≥ 300 cells were counted in 3-4 random fields. Bars are means ± SE. * Statistically 
different,  as  compared  with  control  (Student’s  t-test)  (P < 0 . 0 5 ) .  1 0 % ,  1 0 %  o f  s e r u m  ( v . v ) ;  0 . 2 % ,  0 . 2 %  o f  s e r u m  ( v . v ) ;  G ,  25  m M  o f  g l u c o s e ;  L G ,  l o w - g l u c o s e  ( 2 5  μ M )
other hand, less malignant and more differentiated N-type IMR32 
cells revealed a significant increase (2 fold) of apoptosis in 
low-glucose condition. Furthermore, serum-free only (7 fold) or 
the combination of serum-free and low-glucose (11 fold) resulted 
in dramatic increases in apoptosis in IMR32 cells (Fig. 3A).
Graeber et al. [23] demonstrated that hypoxia can select for 
apoptosis-resistant tumor cells. Hypoxic tumors with a low 
apoptotic index tend to be highly aggressive. Based on those 
observations, the effects of hypoxia on apoptosis of more 
advanced I-type BE(2)C cells and less aggressive N-type IMR32 
cells were examined using double staining with PI and Hoechst. 
There was no increase of apoptosis in 1% O2 for either cell line. 
However, more than a two-fold increase of apoptosis was 
examined under combined hypoxia and serum-free in IMR32, 
but not in BE(2)C cells (Fig. 3B). These data demonstrated that 
hypoxia had minor effects on the apoptosis of NB cells despite 
their different levels of malignancy or degrees of differentiation. 
Furthermore, more malignant and less differentiated tumor cells 
were more resistant to severe nutrient deprivation conditions than 
less malignant and more differentiated tumor cells. 
DLK1 regulates apoptosis induced by serum and/or glucose 
deprivation
Investigators have reported that DLK1 participates in cell 
growth and proliferation in pre-B cells, thymocytes, and gliomas 
[24,25]. However, very little is known about the role of DLK1 
in the apoptosis of tumor cells. To investigate the function of 
DLK1 in the apoptosis of NB, DLK1 was over-expressed using 
retroviral infection containing full-length DLK1 (DLK1-FL). The 
expression of DLK1 was highly amplified in highly malignant 
and less differentiated BE(2)C cells whereas its expression was 
quite low in less advanced and more differentiated IMR32 [18]. 
However, after infection of DLK1-FL, high expression of DLK1 
in IMR32 cells was found. Over-expressed DLK1 expression was 
evaluated by Western blotting (Fig. 4A). The over-expression 
of DLK1-FL caused marked resistance against various nutrient 
deprivation condition-induced apoptosis. In particular, apoptosis 
was dramatically suppressed (43%) by overexpressed DLK1 
under a combination of serum deprivation (0.2%) and low- 
glucose (25 μM) when compared to the control (10% serum and 
25 mM of glucose) (Fig. 4B).Yuri Kim 459
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Fig. 5. DLK1 knock-down increased nutrient depletion-induced apoptosis.  (A)  BE(2)C  cells  were  transfected  with  siDLK1  oligonucleotides  (siDLK1-05  or  siDLK1-07). 
Knockdown  of  DLK1  expression  by  siDLK1-05  or  -07  was  confirmed  b y  W e s t e r n  b l o t t i n g .  β - a c t i n  w a s  u s e d  a s  a  l o a d i n g  c o n t r o l .  ( B )  A f t e r  t r a n s f e c t i o n  w i t h  s i D L K 1  
oligonucletides, cells were incubated with nutrient depletion conditions, either serum-free or low-glucose (25 μM of glucose). The determination of apotosis was performed 
as described in Fig. 2. A total of ≥ 300 cells were counted in 3-4 random  field s. B ars are the m ean±SE. D ifferent letters for given bars indicate values are significantly 
different  from  each  other  (P < 0.05)  (Tukey’s  Post  Hoc  test  after  one-way  ANOVA)
To confirm the role of DLK1 in NB apoptosis, two different 
siDLK1 oligonucleotides were transfected individually into 
highly malignant BE(2)C cells, which have high DLK1 expression 
endogenously. Knock-down DLK1 expression was evaluated by 
Western blotting (Fig. 5A). Both serum and glucose depletion- 
induced apoptosis were significantly increased (relatively 2 fold) 
by DLK1 knock-down in this cell line (Fig. 5B). Collectively, 
these data suggest a critical role of DLK1 in the regulation of 
apoptosis in NB cells. 
Discussion
It has been reported that nutrient deprivation and/or energy 
restriction decrease tumor growth by reducing inflammation 
associated with ageing, elevating glucocorticoid hormone, and 
decreasing angiogenesis [26-28]. Furthermore, nutrient deprivation 
including a lack of serum or glucose is a potent inducer of 
apoptosis in cultures of many different cell types. The absence 
of serum in culture media inhibited cancer cell proliferation and 
increased apoptosis in K562 leukemia cells [29]. Since glucose 
is an exclusive energy source for the brain, a lack of glucose 
may be a critical influence on brain tumor cell metabolism and 
survival. In the present study, we employed human NB cell lines 
as an in vitro model system to examine the effects of the tumor 
cell microenvironment, including nutrient deprivation (serum or 
glucose depletion) and hypoxia, on apoptosis. In this study, in 
less malignant and more differentiated N-type IMR32 cells, 
apoptosis was affected by culture in serum-free conditions and 
further increased in low-glucose condition. This is consistent with 
a report demonstrating that other N-type cells, SK-N-SH-SY5Y 
(Sy5y), showed a marked decrease in cell number by glucose 
withdrawal for 72 hr [3].
Mukherjee et al. [28] reported that dietary restriction reduced 
tumor cell growth by reducing angiogenesis and by enhancing 
apoptosis in syngeneic CT-2A mouse brain cancer. Reduced 
glucose uptake in cancer cells by the glucose metabolic inhibitor, 
2-deoxy-D-glucose, causes apoptosis in breast cancer cells [30]. 
Normal and transformed cancer cells respond to nutrition 
depletion in opposing manners. Whereas normal cells maintain 
their growth by regulating growth signals and nutrition support, 
transformed cancer cells lose responsiveness to most external 
growth signaling. During glucose deprivation, in normal cells, 
glucose uptake and glucose transporter expression is increased 
or modified to compensate. In contrast, when cancer cells are 
stressed by glucose-deprivation, stress related genes are 
upregulated leading to apoptosis [30]. The present study has 
revealed the response of cancer cells, particularly the status of 
malignancy, to nutrient depletion-induced apoptosis.
There was no increased apoptosis under hypoxia (1% O2) 
despite different levels of malignancy or the degree of differentiation. 
These data are consistent with a study [31] demonstrating that 
NB cells treated under hypoxia (1% O2) for 72 hr did not show 
any substantial changes in cell death, suggesting that hypoxia 
has minor effects on apoptosis in NB cells despite different levels 
of malignancy or degrees of differentiation.
Many genetic abnormalities have been identified and used 
clinically for prognosis of NB, such as MYCN amplification. 
MYCN amplification has been related to advance stage and 
adverse prognosis of NB [32,33]. Different malignant stages of 
IMR32 and BE(2)C cells showed MYCN-amplification (data not 
shown) [34]. However, despite the over-expression of MYCN 
in both cell lines, I-type BE(2)C cells were more resistant to 
stress-induced apoptosis than N-type IMR 32 cells in the present 
study. This result indicates that tumor cell malignancy and 
differentiation stage are more important than MYCN status to 
regulate tumor cell growth and apoptosis, suggesting an 
involvement of other genetic and/or epigenetic factors. It was 
previously demonstrated that DLK1 constituted an important role 
in tumorigenicity and stem cell-like functionality [18], which 460 Nutrient depleted microenvironments and apoptosis
supported the pro-survival function of this protein. It has also 
been reported that poorly differentiated and more malignant 
I-type BE(2)C cells expressed more DLK1 than more 
differentiated and less aggressive IMR32 cells [18], supporting 
the pro-survival role of DLK1 in malignancy and differentiation. 
The over-expression of this particular stem cell gene, DLK1, was 
able to ameliorate apoptosis in both low-serum (0.2%) and 
low-glucose (25 uM) conditions, having a potent effect on 
survival in IMR32 cells. Furthermore, knock-down of DLK1 
enhanced apoptosis in a microenvironment characterized by a 
lack of serum and glucose. These data are consistent with a 
previous study where exogenous DLK1 inhibited an increase of 
apoptosis induced by AS2O3 in K562 leukemia cells [35]. Taken 
together, the present results demonstrate that an elevated DLK1 
level provided a survival advantage for NB cells in a poor 
microenvironment characterized by serum and glucose depriva-
tion. For future research, it is necessary to determine the stress- 
related signal mechanism for triggering apoptosis by nutrient 
deprivation. The findings from this study raise the interesting 
potential for further mechanistic studies to investigate DLK1- 
involved signal pathways ameliorating apoptosis in NB.
The prevention and treatment of NB remains a major challenge. 
Therefore, the development of a potential new preventive and 
therapeutic strategy is desirable. The implementation of nutrient 
deprivation in cancer prevention as well as therapeutic strategies, 
could be effective without having adverse side effects. Furthermore, 
DLK1 could provide a novel therapeutic strategy for regulating 
apoptosis in NB cells.
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